IQVIA Holdings Inc (IQV) Balance Sheet

A balance sheet shows what a company owns and owes, and shareholders' equity, at a single point in time.

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.

Total Assets Chart for IQVIA Holdings Inc

IQVIA Holdings Inc (IQV) total assets for FY2025 were USD 29.9B, a 11.3% change from FY2024. IQVIA Holdings Inc's total assets grew from USD 2.3B in 2011 to USD 29.9B in 2025 (1189.1% over 14 years). Total assets compound annual growth rate: 5-year CAGR of 4.0%, 10-year CAGR of 22.5%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Assets (US Dollars)

R&D as % of Revenue

Compare with

Key Stats

Market Cap
$38.26B
Implied Share Price
$232.43
Enterprise Value
$52.85B
Revenue (TTM)
$16.98B
EBITDA
$3.05B
Profit Margin
8.10%
Trailing P/E
28.91
Forward P/E
18.25
Price/Book (MRQ)
6.27
Price/Sales (TTM)
2.25
EV/EBITDA
14.98
EV/Revenue
3.11
Dividend Yield
—
Book Value
$37.49
Free Cash Flow (FY2025)
$2.05B
Free Cash Flow Yield
5.36%

Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.